Precision revisited: targeting microcephaly kinases in brain tumors

G Pallavicini, GE Berto, F Di Cunto - International Journal of Molecular …, 2019 - mdpi.com
Glioblastoma multiforme and medulloblastoma are the most frequent high-grade brain
tumors in adults and children, respectively. Standard therapies for these cancers are mainly …

A new way to treat brain tumors: targeting proteins coded by microcephaly genes? Brain tumors and microcephaly arise from opposing derangements regulating …

PY Lang, TR Gershon - Bioessays, 2018 - Wiley Online Library
New targets for brain tumor therapies may be identified by mutations that cause hereditary
microcephaly. Brain growth depends on the repeated proliferation of stem and progenitor …

Inhibiting microcephaly genes as alternative to microtubule targeting agents to treat brain tumors

G Iegiani, F Di Cunto, G Pallavicini - Cell Death & Disease, 2021 - nature.com
Medulloblastoma (MB) and gliomas are the most frequent high-grade brain tumors (HGBT)
in children and adulthood, respectively. The general treatment for these tumors consists in …

The Yin and Yang of autosomal recessive primary microcephaly genes: insights from neurogenesis and carcinogenesis

X Zhou, Y Zhi, J Yu, D Xu - International Journal of Molecular Sciences, 2020 - mdpi.com
The stem cells of neurogenesis and carcinogenesis share many properties, including
proliferative rate, an extensive replicative potential, the potential to generate different cell …

Recent therapeutic advances for treating medulloblastoma: focus on new molecular targets

AL Schmidt, AL Brunetto… - CNS & Neurological …, 2010 - ingentaconnect.com
Medulloblastoma is the most common malignant brain tumor in children. This malignant
tumor of the cerebellum commonly affects children and is believed to arise from the …

Understanding the molecular complexity of medulloblastoma

RJ Packer, EP Hoffman - Nature Reviews Neurology, 2012 - nature.com
The understanding and treatment of medulloblastoma, the most common childhood
malignant brain tumour, is rapidly evolving. Three complementary deep-sequencing studies …

Special Issue “Tumors of the Nervous System: New Insights into Signaling, Genetics and Therapeutic Targeting”

S Di Bartolomeo, M Segatto - International Journal of Molecular Sciences, 2022 - mdpi.com
This Special Issue focused on the current understanding of signaling pathways as well as
genetic and epigenetic features involved in the pathogenesis of brain tumors and other …

Clinical and pre-clinical utility of genomics in medulloblastoma

C Nör, V Ramaswamy - Expert Review of Neurotherapeutics, 2018 - Taylor & Francis
Introduction: Integrated genomics has significantly advanced our understanding of
medulloblastoma heterogeneity. It is now clear that it actually comprises at least four distinct …

Molecular targeted therapies: time for a paradigm shift in medulloblastoma treatment?

L Gatto, E Franceschi, A Tosoni, V Di Nunno… - Cancers, 2022 - mdpi.com
Simple Summary In the last decade, medulloblastoma entered the molecular era, with
progressive advances in the knowledge of the molecular biology of this rare tumor. These …

Targeting MAPK in cancer 2.0

E Rovida, I Tusa - International Journal of Molecular Sciences, 2022 - mdpi.com
Mitogen-activated protein kinase (MAPK) pathways are prominently involved in the onset
and progression of cancer. In particular, aberrant activation of MAPK pathways is mostly the …